⌘K

Login Start Free

Home/Filings/4/0001181431-10-003563

4//SEC Filing

RAAB G KIRK 4

Accession 0001181431-10-003563

CIK 0001178711other

View on SEC.gov Company Profile

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 6:19 PM ET

Size

5.6 KB

Accession

0001181431-10-003563

Insider Transaction Report

Form 4

Period: 2010-01-14

Transcept Pharmaceuticals IncTSPT

Director

Transactions

Award
Common Stock Option (right to buy)
2010-01-14+5,000→ 5,000 total
Exercise: $8.21Exp: 2020-01-14→ Common Stock (5,000 underlying)

Footnotes (1)

[F1]The option vests in twelve equal monthly installments beginning February 14, 2010.

Documents

1 file

4
rrd263077.xmlPrimary
RAAB 01-14-2010

Issuer

Transcept Pharmaceuticals Inc

CIK 0001178711

Entity typeother

Related Parties

1

filerCIK 0001210530

Filing Metadata

Form type: 4
Filed: Jan 18, 7:00 PM ET
Accepted: Jan 19, 6:19 PM ET
Size: 5.6 KB

View on SEC.gov